Is Hot Stock BMY a Smart Buy Right Now?

Bristol Myers Squibb (BMY) trends as investors eye its potential. Analysts weigh recent performance, pipeline, and market position to decide if it's a buy. The pharma giant draws attention amid sector volatility and health trends. Key facts include earnings outlook and competitive edge in drugs. Traders debate risks versus rewards before jumping in on this buzzing stock. Read more about this...